Gender dysphoria — assessment, risk, and affirming pathway (MEQ)

(i) Definition and differentials. Gender dysphoria (DSM-5-TR): marked incongruence between experienced gender and assigned sex for ≥6 months with clinically significant distress/impairment. Here: sustained he/him identity, binder use, sex-characteristic distress, functional impact — consistent with gender dysphoria, not mere fashion exploration. BDD: preoccupation with perceived defect (e.g. nose) without gender-identity incongruence as the core. Temporary exploration: short-lived, low intensity, no persistent desire for medical/social transition of identity. Co-occurrence of anxiety/autistic traits does not automatically negate GD.[1][3]

(ii) Assessment and risk. Gender developmental history (onset, persistence, insistence, consistency); social transition; body goals; full MSE; depression (PHQ-9 16); suicide/self-harm history (prior overdose) with current passive death wish — complete risk assessment (intent, plan, means, protective factors) and safety plan. Screen ASD thoroughly (communication adaptations); trauma/rejection; substances; psychosis (absent). Collateral with consent (school, both parents). Document function and family conflict.[2][7][3]

(iii) Affirmative principles and conversion. Affirmative care: respect name/pronouns; reduce stigma; explore identity without coercion; treat mental illness in parallel; shared decisions with realistic expectations. Conversion counselling aimed at changing gender identity is inappropriate; recalled conversion exposure associates with distress and suicide attempts — do not collude with the rejecting parent's demand for conversion.[4][6][2]

(iv) Capacity and consent. Decision-specific capacity for testosterone: understanding of benefits, risks (irreversible voice deepening, fertility impact, medical monitoring), alternatives, and unknowns; retention; weighing values; communicating choice. At 17, apply jurisdiction-specific mature-minor/parental responsibility frameworks; involve supportive parent; address dissent without conversion. Fertility counselling essential before hormones. Heightened standards for partially irreversible steps; multidisciplinary documentation.[5][6][8]

(v) Multidisciplinary plan. Immediate: safety planning, treat depression/anxiety (psychotherapy ± SSRI per standard youth depression pathways with monitoring), school liaison, family sessions (supportive parent engagement; educate rejecting parent against conversion). Specialist gender service referral for adolescent pathway assessment; endocrine liaison only after readiness and local criteria; autism-informed communication. Do not start unsupervised testosterone in general psychiatry. Review risk frequently; escalate if active suicidality. Long-term: ongoing MH care even if medical transition proceeds.[5][6][8][7]